Medigen Biotechnology Corp. (TPEX: 3176)
35.80
+0.10 (0.28%)
Sep 11, 2024, 11:26 AM CST
Medigen Biotechnology Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 1,873 | 2,223 | 2,041 | 2,145 | 2,207 | 813.69 | Upgrade
|
Short-Term Investments | 729.05 | 2,364 | 3,040 | 800 | - | 25.21 | Upgrade
|
Trading Asset Securities | - | 0.49 | 54.23 | 53.6 | 54.2 | 77.22 | Upgrade
|
Cash & Short-Term Investments | 2,602 | 4,588 | 5,135 | 2,998 | 2,261 | 916.11 | Upgrade
|
Cash Growth | -44.02% | -10.67% | 71.28% | 32.62% | 146.78% | -20.02% | Upgrade
|
Accounts Receivable | 346.66 | 328.89 | 398.31 | 800.22 | 151.21 | 151.25 | Upgrade
|
Other Receivables | 90.66 | 124.72 | 66.37 | 35.46 | 130.51 | 3.35 | Upgrade
|
Receivables | 437.31 | 453.61 | 464.69 | 835.68 | 281.72 | 154.6 | Upgrade
|
Inventory | 639.47 | 546.91 | 692.62 | 752.87 | 323.29 | 135.27 | Upgrade
|
Prepaid Expenses | 23.97 | 33.61 | 382.35 | 99.59 | - | - | Upgrade
|
Other Current Assets | 33.97 | 86.4 | 57.93 | 231.96 | 155.9 | 106.15 | Upgrade
|
Total Current Assets | 3,736 | 5,708 | 6,733 | 4,918 | 3,022 | 1,312 | Upgrade
|
Property, Plant & Equipment | 1,985 | 2,043 | 2,198 | 2,189 | 2,166 | 2,540 | Upgrade
|
Long-Term Investments | 601.08 | 292.87 | 307.33 | 363.71 | 156.49 | 222.47 | Upgrade
|
Goodwill | 76.18 | 76.18 | 76.18 | 76.18 | 76.18 | 76.18 | Upgrade
|
Other Intangible Assets | 27.46 | 30.36 | 36.9 | 48.08 | 79.34 | 105.3 | Upgrade
|
Long-Term Deferred Tax Assets | 326.47 | 327.5 | 480.94 | 522.18 | 555.68 | 519.2 | Upgrade
|
Other Long-Term Assets | 38.97 | 49.1 | 150.42 | 81.75 | 97.02 | 53.26 | Upgrade
|
Total Assets | 6,791 | 8,527 | 9,982 | 8,199 | 6,152 | 4,829 | Upgrade
|
Accounts Payable | 109.74 | 122.57 | 185.01 | 163.94 | 110 | 107.72 | Upgrade
|
Short-Term Debt | 315.9 | 402.6 | 328 | 300 | 475 | 375 | Upgrade
|
Current Portion of Long-Term Debt | 40.03 | 1,728 | 28.86 | 21.34 | 21.39 | 110.89 | Upgrade
|
Current Portion of Leases | 17.94 | 17.32 | 13.13 | 3.32 | 3.02 | 11.46 | Upgrade
|
Current Income Taxes Payable | 16.11 | 24.63 | 22.99 | - | - | - | Upgrade
|
Current Unearned Revenue | 225.99 | 135 | 130.4 | 244.42 | 113.92 | 101.89 | Upgrade
|
Other Current Liabilities | 313.41 | 349.37 | 343.94 | 331.89 | 210.47 | 223.5 | Upgrade
|
Total Current Liabilities | 1,039 | 2,780 | 1,052 | 1,065 | 933.8 | 930.46 | Upgrade
|
Long-Term Debt | 369.14 | 449.1 | 2,129 | 470.77 | 486.37 | 846.01 | Upgrade
|
Long-Term Leases | 261.78 | 267.53 | 275.32 | 196.64 | 195.67 | 333.46 | Upgrade
|
Long-Term Unearned Revenue | - | - | - | - | - | 0.26 | Upgrade
|
Long-Term Deferred Tax Liabilities | 14.27 | 14.15 | 14.24 | 14.35 | 18.15 | 21.99 | Upgrade
|
Other Long-Term Liabilities | 10.28 | 10.28 | 29.53 | 15.89 | 7.62 | 2.13 | Upgrade
|
Total Liabilities | 1,702 | 3,530 | 3,511 | 1,773 | 1,653 | 2,144 | Upgrade
|
Common Stock | 1,392 | 1,393 | 1,394 | 1,394 | 1,390 | 1,390 | Upgrade
|
Additional Paid-In Capital | 491.52 | 968.14 | 1,562 | 1,109 | 1,101 | 298.22 | Upgrade
|
Retained Earnings | -213.3 | -747.51 | -727.98 | -52.82 | -631.38 | -300.99 | Upgrade
|
Comprensive Income & Other | 4.27 | -22.45 | -34.12 | -54.96 | -44.37 | -25.97 | Upgrade
|
Total Common Equity | 1,675 | 1,592 | 2,194 | 2,394 | 1,815 | 1,361 | Upgrade
|
Minority Interest | 3,414 | 3,405 | 4,277 | 4,032 | 2,684 | 1,324 | Upgrade
|
Shareholders' Equity | 5,089 | 4,997 | 6,471 | 6,426 | 4,499 | 2,685 | Upgrade
|
Total Liabilities & Equity | 6,791 | 8,527 | 9,982 | 8,199 | 6,152 | 4,829 | Upgrade
|
Total Debt | 1,005 | 2,865 | 2,774 | 992.07 | 1,181 | 1,677 | Upgrade
|
Net Cash (Debt) | 1,597 | 1,723 | 2,361 | 2,006 | 1,079 | -760.71 | Upgrade
|
Net Cash Growth | -11.00% | -27.03% | 17.68% | 85.87% | - | - | Upgrade
|
Net Cash Per Share | 11.46 | 12.36 | 16.97 | 14.44 | 7.77 | -5.49 | Upgrade
|
Filing Date Shares Outstanding | 139.23 | 139.35 | 139.45 | 139.36 | 138.99 | 138.99 | Upgrade
|
Total Common Shares Outstanding | 139.23 | 139.35 | 139.45 | 139.36 | 138.99 | 138.99 | Upgrade
|
Working Capital | 2,697 | 2,928 | 5,681 | 3,853 | 2,088 | 381.67 | Upgrade
|
Book Value Per Share | 12.03 | 11.42 | 15.73 | 17.18 | 13.06 | 9.79 | Upgrade
|
Tangible Book Value | 1,571 | 1,485 | 2,081 | 2,270 | 1,660 | 1,180 | Upgrade
|
Tangible Book Value Per Share | 11.28 | 10.66 | 14.92 | 16.29 | 11.94 | 8.49 | Upgrade
|
Land | 330.29 | 330.29 | 354.04 | 354.04 | 354.04 | 354.04 | Upgrade
|
Buildings | 1,467 | 1,465 | 1,506 | 1,500 | 1,495 | 1,494 | Upgrade
|
Machinery | 1,236 | 1,266 | 1,240 | 1,178 | 1,002 | 970.83 | Upgrade
|
Construction In Progress | 2.64 | 21.37 | 14.54 | 4.7 | 17.9 | 119.35 | Upgrade
|
Leasehold Improvements | 3.27 | 3.34 | 3.03 | 2.55 | 1.89 | 1.89 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.